Bi-HRT for chest pain after spontaneous coronary artery dissection in peri- and post-menopausal women

Phase 2, randomised, double-blind trial of estradiol and progesterone in spontaneous coronary artery dissection (SCAD), sponsored by University of Leicester. Primary endpoints: Eligibility, recruitment, and retention feasibility at 12 months, Willingness to consent and treatment adherence feasibility at 12 months and 3 more. Started Aug 2025; status: active, not recruiting.